Continuing the conversation, Juan Granada hears about Guido Ascione’s recent presentation on the global burden of degenerative mitral valve disease at NY Valves 2025.

Juan Granada speaks with Greg Roth about how the GBD data set is used to assess global trends and determine what health problems need to be addressed by the medical community worldwide.

Juan Granada and Pierre Elias continue their conversation on artificial intelligence, including the practical ways it can be implemented in the detection of structural heart disease.

Michael Mack and Caroline Berchuck discuss how the expectations of healthcare delivery in the United States are shifting due to expanded capabilities of AI and digital technology.

Isaac George discusses the one-year clinical results of the novel polymeric leaflet TRIA valve for patients undergoing surgical mitral valve replacement.

Suzanne Baron and David Elison discuss when to intervene in cases of asymptomatic aortic stenosis based on the complete patient profile.

Brian Lindman, Rahul Sharma, and Sreek Vemulapalli share the benefits of using artificial intelligence tools to assist in identifying patients with aortic stenosis.

Brian Lindman, Sammy Elmariah, and David Wood explain how echocardiogram alerts are assisting in the management and evaluation of aortic stenosis patients.

Bernard Prendergast and Jordan Strom discuss the evolution of AS referral and how earlier treatment impacts patient outcomes.

Philippe Généreux, Brad Oldemeyer, and Jennifer Daniel share their experiences treating asymptomatic aortic stenosis patients in the EARLY TAVR trial.